Dudediligence.

Coya Therapeutics, Inc

COYANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$1,952Dec ’24$257,884Mar ’25$163,616Jun ’25$3.6MSep ’25$4.0MDec ’25$251,147Mar ’26$243,745Jun ’26
Net income, by quarter
−$4.0MSep ’24−$2.9MDec ’24−$7.3MMar ’25−$6.1MJun ’25−$2.1MSep ’25−$5.7MDec ’25−$7.2MMar ’26−$6.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$6.0M$3.6M$7.9M
Operating income−$4.9M−$9.8M−$7.9M−$17.2M−$22.6M
Net income−$4.9M−$12.2M−$8.0M−$14.9M−$21.2M
Operating cash flow−$3.9M−$7.2M−$11.2M−$10.3M−$10.7M
Cash$4.3M$5.9M$32.6M$38.3M$46.8M
Shares outstanding2.6M2.6M14.4M16.7M20.9M